BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2428605)

  • 1. Binding of immunoglobulin G from patients with autoimmune thyroid diseases to solubilized guinea pig fat cell membranes crosslinked with 125I-TSH.
    Iida Y; Konishi J; Misaki T; Kasagi K; Endo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1986 Jun; 33(3):333-43. PubMed ID: 2428605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprecipitation of TSH-TSH receptor complexes.
    Parkes AB; Kajita Y; Buckland PR; Howells RD; Rickards CR; Creagh FM; Rees Smith B
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):511-20. PubMed ID: 2985304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
    Konishi J; Iida Y; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):219-26. PubMed ID: 6127208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of immunogenic regions in TSH receptor for Graves' IgG and Hashimoto's IgG].
    Murakami M; Miyashita K; Mori M
    Nihon Rinsho; 1994 Apr; 52(4):1057-62. PubMed ID: 8196164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes.
    Iida Y; Amir SM; Ingbar SH
    Endocrinology; 1987 Nov; 121(5):1627-36. PubMed ID: 3665836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in species specificity of TSH receptor antibodies in Graves' disease and Hashimoto's thyroiditis.
    de Bruin TW
    J Endocrinol Invest; 1988 Jun; 11(6):403-8. PubMed ID: 3209819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.
    Zakarija M; Garcia A; McKenzie JM
    J Clin Invest; 1985 Nov; 76(5):1885-91. PubMed ID: 2997295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
    Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
    Tao TW; Kriss JP
    J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes.
    Iida Y; Konishi J; Kasagi K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):227-31. PubMed ID: 6127209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topics on immunogenic regions in TSH receptors for thyroid disease].
    Murakami M; Mori M
    Rinsho Byori; 1993 Feb; 41(2):128-35. PubMed ID: 7689665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.